BCL-2 (B-cell lymphoma 2) Inhibitors Market - Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: B496CECF88D9EN
Market Monitor Global

Abstracts

Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis.

This report contains market size and forecasts of BCL-2 (B-cell lymphoma 2) Inhibitors in Global, including the following market information:

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global BCL-2 (B-cell lymphoma 2) Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Combination therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of BCL-2 (B-cell lymphoma 2) Inhibitors include AbbVie Inc. and F. Hoffmann-La Roche Ltd. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the BCL-2 (B-cell lymphoma 2) Inhibitors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Segment Percentages, by Type, 2021 (%)

• Combination therapy
• Monotherapy

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Segment Percentages, by Application, 2021 (%)

• Cancer
• Auto-immune diseases
• Other

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies BCL-2 (B-cell lymphoma 2) Inhibitors revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies BCL-2 (B-cell lymphoma 2) Inhibitors revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie Inc.
• F. Hoffmann-La Roche Ltd.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 BCL-2 (B-cell lymphoma 2) Inhibitors Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BCL-2 (B-CELL LYMPHOMA 2) INHIBITORS OVERALL MARKET SIZE

2.1 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size: 2021 VS 2028
2.2 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top BCL-2 (B-cell lymphoma 2) Inhibitors Players in Global Market
3.2 Top Global BCL-2 (B-cell lymphoma 2) Inhibitors Companies Ranked by Revenue
3.3 Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue by Companies
3.4 Top 3 and Top 5 BCL-2 (B-cell lymphoma 2) Inhibitors Companies in Global Market, by Revenue in 2021
3.5 Global Companies BCL-2 (B-cell lymphoma 2) Inhibitors Product Type
3.6 Tier 1, Tier 2 and Tier 3 BCL-2 (B-cell lymphoma 2) Inhibitors Players in Global Market
  3.6.1 List of Global Tier 1 BCL-2 (B-cell lymphoma 2) Inhibitors Companies
  3.6.2 List of Global Tier 2 and Tier 3 BCL-2 (B-cell lymphoma 2) Inhibitors Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size Markets, 2021 & 2028
  4.1.2 Combination therapy
  4.1.3 Monotherapy
4.2 By Type - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue & Forecasts
  4.2.1 By Type - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2017-2022
  4.2.2 By Type - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2023-2028
  4.2.3 By Type - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2021 & 2028
  5.1.2 Cancer
  5.1.3 Auto-immune diseases
  5.1.4 Other
5.2 By Application - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue & Forecasts
  5.2.1 By Application - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2017-2022
  5.2.2 By Application - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2023-2028
  5.2.3 By Application - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2021 & 2028
6.2 By Region - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue & Forecasts
  6.2.1 By Region - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2017-2022
  6.2.2 By Region - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2023-2028
  6.2.3 By Region - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2017-2028
  6.3.2 US BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
  6.3.3 Canada BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
  6.3.4 Mexico BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2017-2028
  6.4.2 Germany BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
  6.4.3 France BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
  6.4.4 U.K. BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
  6.4.5 Italy BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
  6.4.6 Russia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
  6.4.7 Nordic Countries BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
  6.4.8 Benelux BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2017-2028
  6.5.2 China BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
  6.5.3 Japan BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
  6.5.4 South Korea BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
  6.5.5 Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
  6.5.6 India BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2017-2028
  6.6.2 Brazil BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
  6.6.3 Argentina BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2017-2028
  6.7.2 Turkey BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
  6.7.3 Israel BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
  6.7.4 Saudi Arabia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028
  6.7.5 UAE BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AbbVie Inc.
  7.1.1 AbbVie Inc. Corporate Summary
  7.1.2 AbbVie Inc. Business Overview
  7.1.3 AbbVie Inc. BCL-2 (B-cell lymphoma 2) Inhibitors Major Product Offerings
  7.1.4 AbbVie Inc. BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in Global Market (2017-2022)
  7.1.5 AbbVie Inc. Key News
7.2 F. Hoffmann-La Roche Ltd.
  7.2.1 F. Hoffmann-La Roche Ltd. Corporate Summary
  7.2.2 F. Hoffmann-La Roche Ltd. Business Overview
  7.2.3 F. Hoffmann-La Roche Ltd. BCL-2 (B-cell lymphoma 2) Inhibitors Major Product Offerings
  7.2.4 F. Hoffmann-La Roche Ltd. BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in Global Market (2017-2022)
  7.2.5 F. Hoffmann-La Roche Ltd. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. BCL-2 (B-cell lymphoma 2) Inhibitors Market Opportunities & Trends in Global Market
Table 2. BCL-2 (B-cell lymphoma 2) Inhibitors Market Drivers in Global Market
Table 3. BCL-2 (B-cell lymphoma 2) Inhibitors Market Restraints in Global Market
Table 4. Key Players of BCL-2 (B-cell lymphoma 2) Inhibitors in Global Market
Table 5. Top BCL-2 (B-cell lymphoma 2) Inhibitors Players in Global Market, Ranking by Revenue (2021)
Table 6. Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Share by Companies, 2017-2022
Table 8. Global Companies BCL-2 (B-cell lymphoma 2) Inhibitors Product Type
Table 9. List of Global Tier 1 BCL-2 (B-cell lymphoma 2) Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 BCL-2 (B-cell lymphoma 2) Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Inc. Corporate Summary
Table 31. AbbVie Inc. BCL-2 (B-cell lymphoma 2) Inhibitors Product Offerings
Table 32. AbbVie Inc. BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (US$, Mn), (2017-2022)
Table 33. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 34. F. Hoffmann-La Roche Ltd. BCL-2 (B-cell lymphoma 2) Inhibitors Product Offerings
Table 35. F. Hoffmann-La Roche Ltd. BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. BCL-2 (B-cell lymphoma 2) Inhibitors Segment by Type in 2021
Figure 2. BCL-2 (B-cell lymphoma 2) Inhibitors Segment by Application in 2021
Figure 3. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in 2021
Figure 8. By Type - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2017-2028
Figure 9. By Application - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2017-2028
Figure 10. By Region - Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2017-2028
Figure 11. By Country - North America BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2017-2028
Figure 12. US BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 13. Canada BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2017-2028
Figure 16. Germany BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 17. France BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 19. Italy BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 20. Russia BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2017-2028
Figure 24. China BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 25. Japan BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 28. India BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2017-2028
Figure 30. Brazil BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share, 2017-2028
Figure 33. Turkey BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 34. Israel BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 36. UAE BCL-2 (B-cell lymphoma 2) Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Inc. BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. F. Hoffmann-La Roche Ltd. BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)